In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors

Epidermal growth factor receptor (EGFR) and cyclooxygenase-2 (COX-2) are crucial targetable enzymes in cancer management. Therefore, herein, new 2-[(5-((1H-indol-3-yl)methyl)-1,3,4-oxadiazol-2-yl)thio]-N-(thiazol/benzothiazol-2-yl)acetamides (2a–i) were designed and synthesized as EGFR and COX-2 inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Sever, Belgin, Altıntop, Mehlika Dilek, Özdemir, Ahmet, Akalın Çiftçi, Gülşen, Ellakwa, Doha E., Tateishi, Hiroshi, Radwan, Mohamed O., Ibrahim, Mahmoud A. A., Otsuka, Masami, Fujita, Mikako, Ciftci, Halil I., Ali, Taha F. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664637/
https://www.ncbi.nlm.nih.gov/pubmed/33171861
http://dx.doi.org/10.3390/molecules25215190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664637/
https://www.ncbi.nlm.nih.gov/pubmed/33171861
http://dx.doi.org/10.3390/molecules25215190

Ejemplares similares